Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases

Histopathology

Volumn 62, Issue 2, 2013, Pages 305-314

  Kim, Hyojin ^a   Xu, Xianhua ^a,b   Yoo, Seol Bong ^a,b   Sun, Ping Li ^b   Jin, Yan ^a,b   Paik, Jin Ho ^b   Choe, Gheeyoung ^a,b   Jheon, Sanghoon ^b   Lee, Choon Taek ^b   Chung, Jin Haeng ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

ALK; Metastases; Non small cell lung cancer; Primary

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; K RAS PROTEIN; VASCULOTROPIN RECEPTOR;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER GROWTH; CANCER STAGING; COPY NUMBER VARIATION; DISTANT METASTASIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY METASTASIS; LIVER METASTASIS; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDIASTINUM METASTASIS; METASTASIS; MUTATIONAL ANALYSIS; NECK METASTASIS; NEEDLE BIOPSY; PLEURA METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SOFT TISSUE METASTASIS; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84871135647     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04356.x     Document Type: Article

References (24)

1. Pao W, Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol. 2011; 12; 175-180.
2. Mano H. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer. Cancer Sci. 2008; 99; 2349-2355.
3. Soda M, Choi YL, Enomoto M et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448; 561-566.
4. Shaw AT, Solomon B. Targeting anaplastic lymphoma kinase in lung cancer. Clin. Cancer Res. 2011; 17; 2081-2086.
5. Wong DW, Leung EL, So KK et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 2009; 115; 1723-1733.
6. Shaw AT, Yeap BY, Mino-Kenudson M et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J. Clin. Oncol. 2009; 27; 4247-4253.
7. Kim HR, Shim HS, Chung JH et al. Distinct clinical features and outcomes in never-smokers with non-small cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. Cancer 2012; 118; 729-739.
8. Kwak EL, Bang YJ, Camidge DR et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 2010; 363; 1693-1703.
9. Ou SH, Bazhenova L, Camidge DR et al. Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer. J. Thorac. Oncol. 2010; 5; 2044-2046.
10. Camidge DR, Kono SA, Flacco A et al. Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment. Clin. Cancer Res. 2010; 16; 5581-5590.
11. Fidler IJ. Critical determinants of metastasis. Semin. Cancer Biol. 2002; 12; 89-96.
12. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127; 679-695.
13. Salido M, Pijuan L, Martinez-Aviles L et al. Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer. J. Thorac. Oncol. 2011; 6; 21-27.
14. Camidge DR, Theodoro M, Maxson DA et al. Correlations between the percentage of tumor cells showing an ALK (anaplastic lymphoma kinase) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence insitu hybridization-positive non-small cell lung cancer. Cancer 2012; [Epub ahead of print]. doi:10.1002/cncr.27411.
15. Yoo SB, Kim H, Xu X et al. Clinicopathologic implications of ALK gene copy number gain in non-small cell lung cancer. J. Lung Cancer 2011; 10; 87-93.
16. Paik JH, Choe G, Kim H et al. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence insitu hybridization. J. Thorac. Oncol. 2011; 6; 466-472.
17. Travis WD, Brambilla E, Muller-Hermelink HK et al. World Health Organization classification of tumours. Pathology and genetics. Tumours of the lung, pleura, thymus and heart. Lyon: IARC Press, 2004.
18. Kim H, Yoo SB, Choe JY et al. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence insitu hybridization and chromogenic insitu hybridization with correlation of ALK protein expression. J. Thorac. Oncol. 2011; 6; 1359-1366.
19. Chung JH, Choe G, Jheon S et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. J. Thorac. Oncol. 2009; 4; 1490-1495.
20. Martini N, Melamed MR. Multiple primary lung cancers. J. Thorac. Cardiovasc. Surg. 1975; 70; 606-612.
21. Girard N, Deshpande C, Lau C et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am. J. Surg. Pathol. 2009; 33; 1752-1764.
22. Rossi A, Galetta D, Bottiglieri L, Stufano V, Barberis M. Evaluation of ALK gene status in primary lung adenocarcinoma and matched metastases. J. Thorac. Oncol. 2011; 6; 1146.
23. Yatabe Y, Matsuo K, Mitsudomi T. Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma. J. Clin. Oncol. 2011; 29; 2972-2977.
24. Gallegos Ruiz MI, Floor K, Vos W et al. Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence insitu hybridization and chromogenic insitu hybridization. Histopathology 2007; 51; 631-637.